Ozempic: A New Era for Weight Loss, Diabetes, and Obesity?

UCSF Insights Panel Discussion

Is Ozempic too good to be true? How does it work? Is it safe for everyone? What happens when you stop taking it? 

Our panel of UCSF experts explore the root causes of excess weight, how weight-loss drugs work, and their potential for transforming care for people with obesity and diabetes, delving into these emerging new therapies for what they mean for the future of the field, including the pioneering concept of precision nutrition. Featuring our Nadav Ahituv PhD, Director of UCSF Institute for Human Genetics and Professor in Department of Bioengineering & Therapeutic Sciences; Sarah Kim MD, Director of UCSF Diabetes Teaching Center and the Diabetes Clinic at Zuckerberg San Francisco General; Suneil Koliwad MD PhD, Chief in the Division of Endocrinology and Metabolism, and Mark Anderson, MD PhD, Director of UCSF Diabetes Center.